Envestnet Asset Management Inc. boosted its stake in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX – Get Rating) by 5.5% in the 4th quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 284,200 shares of the pharmaceutical company’s stock after purchasing an additional 14,768 shares during the […]
Mitsubishi UFJ Kokusai Asset Management Co. Ltd. grew its holdings in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX – Get Rating) by 10.6% during the fourth quarter, according to the company in its most recent filing with the SEC. The fund owned 196,887 shares of the pharmaceutical company’s stock after acquiring an additional 18,898 shares during the quarter. […]
Handelsbanken Fonder AB lessened its position in shares of Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX – Get Rating) by 7.3% in the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 330,761 shares of the pharmaceutical company’s stock after selling 26,056 shares during the period. Handelsbanken […]
Retirement Systems of Alabama reduced its stake in shares of Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX – Get Rating) by 1.0% during the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 294,834 shares of the pharmaceutical company’s stock after selling 2,949 shares during the quarter. Retirement […]
Princeton Global Asset Management LLC decreased its stake in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX – Get Rating) by 0.4% in the fourth quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 14,968 shares of the pharmaceutical company’s stock after selling 55 shares during the quarter. […]